advanced search

Welcome: Guest

log in

Company Study of China Enterprise Company Limited

2007

Publication Date August 2007
Publisher Research in China
Product Type Report
Pages 26
ISBN Number not applicable
Product Code RIC00276
Buy this product or for assistance call +44 20 7060 7474

Summary

The land development volume has gradually declined in Shanghai since 2004, reaching the lowest of the history in 2006, which led to the lack of housing supply in Shanghai market in 2007 and 2008. From the aspect of market demand, the housing market in Shanghai still kept 30 million sq. meters sales area although under macro adjustment in 2005 and 2006. In the beginning of 2007, the market demand in Shanghai recovered a bit, but the comparatively inadequate supply will intensify the contradiction of supply and demand in the market.

Currently, the company has 140,000 sq meters property for rent, most of which are office buildings and business units. The rent revenue was remarkable; the gross profit margin has exceeded 55%. According to the company plan, its rental area will increase to 250-300 thousand sq meters within three years. It is forecasted that its annual rent will amount to more than RMB 120 million in 2009, and RMB 274 million in 2011.

Content

  • 1 Development of Shanghai Real Estate Industry
    • 1.1 Market Recovers
    • 1.2 Return of Commercial Real Estate
  • 2 Company Profile
    • 2.1 Overview
    • 2.2 Operation
    • 2.3 Strategic Goal and Management Mode
    • 2.4 Capital Pressure Promotes Group Capital Inflow Process
  • 3 Main Businesses
    • 3.1 Developing Property Maintains Steady Growth
    • 3.2 Steady Increase of Leasing Property Scale
  • 4 Analysis and Forecast of Performance in Following Three Years
    • 4.1 High gross profit may lead to the high liquidation of land value-added tax
    • 4.2 Periodical expense rate will drop year by year
    • 4.3 Investment Return
    • 4.4 Net Profit
  • 5 Risks
Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)

Industry Events

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>